FREE SHIPPING IS AVAILABLE ON ORDERS OVER $300
FREE SHIPPING IS AVAILABLE ON ORDERS OVER $300
Product Specifications
AOD-9604 is a modified fragment of human growth hormone (HGH), studied for its potential effects on lipid metabolism and adipose tissue regulation. Provided in a 5mg lyophilized vial for laboratory research
Requires reconstitution with bacteriostatic water (Sold Here)
$59.99
About this Peptide
Pharmaceutical-grade. ≥99% purity. For research use only.
AOD-9604 (Advanced Obesity Drug peptide) is a research-grade peptide derived from the C-terminus of human growth hormone (HGH), specifically the 176–191 amino acid sequence. Unlike full-length HGH, AOD-9604 has been studied for its ability to selectively influence fat metabolism without affecting blood sugar or cell proliferation markers.
Research has explored AOD-9604’s potential mechanisms in:
Each 5mg vial of AOD-9604 is synthesized with ≥99% purity and lyophilized under sterile conditions to preserve molecular stability for ongoing investigative use.
Storage & Handling: Store lyophilized peptide at -20°C. After reconstitution with bacteriostatic water, keep refrigerated at 2–8°C and use within 30 days. For in vitro laboratory research only. Not for human or animal use.
Disclaimer: This product is sold strictly for laboratory research purposes. It is not intended for human consumption, medical diagnosis, or therapeutic application. Please refer to your institution’s compliance protocols before use.
Name
AOD-9604 (Advanced Obesity Drug peptide)
Concentration
5mg per vial
Form
Lyophilized peptide powder
Purity
≥99%, confirmed by HPLC and MS
Packaging
Sterile, sealed vial
Storage
-20°C in a dark, dry environment
AOD-9604 is a synthetic peptide analogue derived from amino acids 176–191 of the C-terminal fragment of human growth hormone (hGH). It was developed to isolate the lipolytic properties of hGH without engaging the full-length receptor in a manner that stimulates IGF-1 production or proliferative activity. This structural selectivity makes AOD-9604 a precise research tool for studying adipose tissue metabolism independently of broader growth hormone signaling cascades.
AOD-9604 is investigated primarily in the context of lipid metabolism, adipose tissue regulation, and body composition research. Scientific studies have explored its capacity to stimulate lipolysis and inhibit lipogenesis through interactions with beta-3 adrenergic receptors, providing researchers with a targeted model for studying fat metabolism pathways without the systemic hormonal effects associated with full-length hGH administration.
While AOD-9604 is structurally derived from hGH, it differs significantly in its receptor binding profile and downstream signaling activity. Full-length hGH binds to the growth hormone receptor and stimulates IGF-1 production, driving anabolic and proliferative effects across multiple tissue types. AOD-9604 lacks this broad receptor engagement, confining its research activity to lipolytic pathways, which makes it a more targeted and mechanistically distinct compound for metabolic research models.
Lyophilized AOD-9604 should be stored at -20°C in a dry, light-protected environment prior to use. Reconstitution should be performed in a sterile laboratory setting using bacteriostatic water as the preferred diluent for multi-dose research applications. The reconstituted solution should be refrigerated at 2–8°C and used within the recommended timeframe, with aliquoting advised to prevent peptide degradation from repeated freeze-thaw cycles.
